Commentary: Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers by Rachael Glassey et al.
GENERAL COMMENTARY
published: 31 January 2017
doi: 10.3389/fpsyg.2017.00121
Frontiers in Psychology | www.frontiersin.org 1 January 2017 | Volume 8 | Article 121
Edited by:
Michael Noll-Hussong,
University of Ulm, Germany
Reviewed by:
Karim A. Sarhane,





This article was submitted to
Psychology for Clinical Settings,
a section of the journal
Frontiers in Psychology
Received: 08 December 2016
Accepted: 17 January 2017
Published: 31 January 2017
Citation:
Glassey R, Saunders C and
Hardcastle SJ (2017) Commentary:
Bilateral risk-reducing mastectomy is




mastectomy is the safest strategy in
BRCA1 carriers
Rachael Glassey 1*, Christobel Saunders 1 and Sarah J. Hardcastle 2
1 Faculty of Medicine, School of Surgery, Dentistry and Health Sciences, University of Western Australia, Perth, WA, Australia,
2Health Psychology and Behavioural Medicine Research Group, Faculty of Health Sciences, School of Psychology and
Speech Pathology, Curtin University, Perth, WA, Australia
Keywords: familial cancer, bilateral prophylactic mastectomy, risk management, counseling, psychological
support
A commentary on
Bilateral risk-reducing mastectomy is the safest strategy in BRCA1 carriers
by Pilgrim, S., and Pain, S. (2014). Eur. J. Surg. Oncol. 40, 670–672. doi: 10.1016/j.ejso.2014.02.218
Pilgrim and Pain (2014) suggest the best option for BRCA1 carriers is to undergo a bilateral
prophylactic mastectomy (BPM). Pilgrim and colleagues suggest that a BPM combined with
salpingo-oophorectomy at 25 years old is the best option to minimize risk of developing breast
cancer (BC) and ovarian cancer. Undergoing BPM may be the safest option to reduce incidence
and mortality, however a diagnosis of a BRCA mutation does not confer a 100% risk and BPM is
not the only risk management option. The risk (to 70 years) of developing BC for a BRCA1 carrier
is estimated to be about 60% (Mavaddat et al., 2013) and it has been suggested women with BRCA
mutations may have up to 80% lifetime risk (National Cancer Institute, 2013). We contend BPM
it is not necessarily the best option for all women, especially at such a young age and without a
process of fully informed and supported decision-making. The purpose of the current paper is to
highlight that health professional recommendations to undergo a BPM may lead to patient regret
and clinician blame. Our commentary highlights the consequences of undergoing a BPM without
a process of fully informed decision-making, including potential emotional and psychological
complications associated with body image and sexuality. We suggest health professionals should
provide patients with all options, including screening, medical risk reduction (e.g., tamoxifen) and
BPM. We propose all women considering BPM should be referred to an experienced counselor
or psychologist to discuss their options, and ensure these individuals are making an informed
decision and not one driven by fear or based on the perceived bias of one health professional or
other individual, such as anecdotal advice from well-meaning friends or family.
Women with a BRCA mutation are often extremely fearful about developing BC (Dean, 2016).
As such, many are driven to undergo BPM out of fear without considering the consequences
(Frost et al., 2000). Furthermore, there is evidence to suggest that discussions initiated by a health
professional to opt for BPM may lead to regret post-surgery in some women. For example, Payne
et al. (2000) found that initiation of discussion about BPM could influence women’s decision-
making. They found that those who had regrets about their surgery reported the discussion about
BPM was initiated by a health practitioner. They concluded that a practitioner-initiated discussion
about undergoing BPM predicted regret. More recently, there are reports of litigation on the
basis that women were ill-informed of treatment options and left with complications following
BPM. Early in 2016 an Australian newspaper reported a story of two women suing a hospital
following BPM on the basis that health professionals did not fully explain treatment options to
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them (Cavazzini and App, 2016). If health professionals
encourage BPM simply based on statistical risk reduction
and without taking into account other options and potential
consequences of surgery, it may increase psychological issues
post-surgery and lead to women blaming health professionals
if they are unhappy with the outcome or feel they were not
fully informed of other options. Regret may be more common
if the solution to a proven BRCA mutation is practitioners
recommending BPM and women feeling rushed into surgical
options, primarily out of fear, and without a process of informed
and supported decision-making (Taylor and Tischkowitz, 2014).
Health professionals should discuss with women of all their
options in an unbiased fashion, which includes BPM as one
option. Women who wish to consider the irreversible procedure
of BPM should then be referred by their practitioner to a
psychologist to discuss these options, including deferring a
decision to a later date, especially if women are as young as 25
years old.
Statistically BPM may be the best option to reduce the risk
of developing BC. Although the risk is not reduced to zero,
BPM can reduce the relative risk that BC will develop by
over 90% (Hartmann et al., 1999; Rebbeck et al., 2004). This
is important to highlight since there may be the perception
amongst patients that BPM reduces the cancer risk to zero,
which is not true. The decision to undergo BPM is a personal
decision and is often fraught with emotional, psychological
and physical complications (den Heijer et al., 2012; Hallowell
et al., 2012). The decision needs to be informed and made
by the individual (Taylor and Tischkowitz, 2014). A decision
to undergo BPM needs to take into account factors such as
having children, breast feeding, quality of life and intimacy.
A woman’s perception of her body can change as a result
of BPM, and this can contribute to women feeling less
feminine. Women often report their reconstructed breasts look
and feel unnatural which makes them feel less attractive and
impacts their sex life (Altschuler et al., 2008; Brandberg et al.,
2008). Poor cosmetic outcomes, complications from surgery
and/or reconstruction are not uncommon and often associated
with greater psychological distress (Bebbington Hatcher and
Fallowfield, 2003).
For these reasons we suggest that there is a need to provide
counseling/psychological consultation to BRCA positive women
who are considering BPM. This approach is less likely to lead
to practitioner blame and will ensure women are fully informed
about the best course of action for them before deciding and
undergoing BPM. Patenaude et al. (2008) demonstrated support
for psychological consultation before BPM by an experienced
and knowledgeable practitioner. Women in their study suggested
it would be helpful to anticipate what they might feel after
undergoing surgery. An experienced counselor/psychologist is
equipped to discuss psychological and emotional implications
of a BPM to ensure women have explored all the options
and are able to make an informed decision. Women may
often not be able or willing to understand the ramifications of
this surgery because they are so driven by fear. Emphasis on
ensuring women understand the realities of BPM, and making
sure they are ready for such surgery, will likely lead to more
satisfaction and less psychological adjustment issues following
surgery.
In summary, women with BRCA mutations should be fully
informed and supported in their decisions around treatment both
now and into the future, including understanding both benefits
and potential complications of all treatment options. Women
who wish to consider BPM should be referred for counseling and
psychological support to ensure they understand their options
and the implications of undergoing BPM.
AUTHOR CONTRIBUTIONS
RG and SH conceived the ideas presented in the article. RG
drafted the article. Both SH and CS assisted in drafting and
refining the article prior to submission.
REFERENCES
Altschuler, A., Nekhlyudov, L., Rolnick, S. J., Greene, S. M., Elmore, J. G., and
West, C. N., et al (2008). Positive, negative, and disparate—women’s differing
long-term psychosocial experiences of bilateral or contralateral prophylactic
mastectomy. Breast J. 14, 25–32. doi: 10.1111/j.1524-4741.2007.00521.x
Bebbington Hatcher, M., and Fallowfield, L. (2003). A qualitative study looking at
the psychosocial implications of bilateral prophylactic mastectomy. Breast 12,
1–9. doi: 10.1016/S0960-9776(02)00135-2
Brandberg, Y., Sandelin, K., Erikson, S., Jurell, G., Liljegren, A., and Lindblom,
A., et al (2008). Psychological reactions, quality of life, and body image
after bilateral prophylactic mastectomy in women at high risk for breast
cancer: a prospective 1-year follow-up study. J. Clin. Oncol. 26, 3943–3949.
doi: 10.1200/JCO.2007.13.9568
Cavazzini, M., and App (2016). Prophylactic Mastectomy Ends in Court.
Chatswood, DC: Australian Doctor.
Dean, M. (2016). “It’s not if I get cancer, it’s when I get cancer”: BRCA-positive
patients’ (un)certain health experiences regarding hereditary breast and
ovarian cancer risk. Soc. Sci. Med.. 163, 21–27. doi: 10.1016/j.socscimed.2016.
06.039
den Heijer, M., Seynaeve, C., Timman, R., Duivenvoorden, H. J., Vanheusden, K.,
Tilanus-Linthorst, M., et al. (2012). Body image and psychological distress after
prophylactic mastectomy and breast reconstruction in genetically predisposed
women: a prospective long-term follow-up study. Eur. J. Cancer 48, 1263–1268.
doi: 10.1016/j.ejca.2011.10.020
Frost, M. H., Schaid, D. J., Sellers, T. A., Slezak, J. M., Arnold, P. G., Woods,
J. E., et al (2000). Long-term satisfaction and psychological and social
function following bilateral prophylactic mastectomy. JAMA 284, 319–324.
doi: 10.1001/jama.284.3.319
Hallowell, N., Baylock, B., Heiniger, L., Butow, P. N., Patel, D., and Meiser,
B., et al (2012). Looking different, feeling different: women’s reactions
to risk-reducing breast and ovarian surgery. Fam. Cancer 11, 215–224.
doi: 10.1007/s10689-011-9504-4
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P., et
al (1999). Efficacy of bilateral prophylactic mastectomy in women with a family
history of breast cancer. New Engl. J. Med. 340, 77–84.
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., et al.
(2013). Cancer risks for BRCA1 and BRCA2 mutation carriers: results
from prospective analysis of EMBRACE. J. Natl. Cancer Inst. 105, 812–822.
doi: 10.1093/jnci/djt095
Frontiers in Psychology | www.frontiersin.org 2 January 2017 | Volume 8 | Article 121
Glassey et al. Preventative Mastectomy Safest for BRCA1
National Cancer Institute (2013). BRCA1 and BRCA2: Cancer Risk and Genetic
Testing. Available online at: http://www.cancer.gov/cancertopics/factsheet/
Risk/BRCA
Patenaude, A. F., Orozco, S., Li, X., Kaelin, C. M., Gadd, M., and Matory, Y.,
et al (2008). Support needs and acceptability of psychological and peer
consultation: attitudes of 108 women who had undergone or were considering
prophylactic mastectomy. Psychooncology 17, 831–843. doi: 10.1002/
pon.1279
Payne, D. K., Biggs, C., Tran, K. N., Borgen, P. I., andMassie,M. J. (2000).Women’s
regrets after bilateral prophylactic mastectomy. Ann. Surg. Oncol. 7, 150–154.
doi: 10.1007/s10434-000-0150-6
Pilgrim, S., and Pain, S. (2014). Bilateral risk-reducing mastectomy is the safest
strategy in BRCA1 carriers. Eur. J. Surg. Oncol. 40, 670–672. doi: 10.1016/j.ejso.
2014.02.218
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van’t Veer, L., Garber, J.
E., et al (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in
BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J. Clin. Oncol.
22, 1055–1062. doi: 10.1200/JCO.2004.04.188
Taylor, A., and Tischkowitz, M. (2014). Informed decision-making is the key
in women at high risk of breast cancer. Eur. J. Surg. Oncol. 6, 667–669.
doi: 10.1016/j.ejso.2014.02.219
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Glassey, Saunders and Hardcastle. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) or licensor are credited and that the original publication in this
journal is cited, in accordance with accepted academic practice. No use, distribution
or reproduction is permitted which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 3 January 2017 | Volume 8 | Article 121
